Post-GPI attachment to proteins 2 pseudogene

The post-GPI attachment to proteins 2 pseudogene (ENSG00000271527, LOC100420658) is a genomic region annotated as a pseudogene related to the PGAP2 gene, which is involved in GPI-anchor protein biosynthesis[1]. Pseudogenes are segments of DNA that resemble functional genes but are nonfunctional due to mutations or lack of necessary regulatory elements. There is no evidence this pseudogene encodes an active protein or plays a recognized biological role in humans[1]. It is not considered a therapeutic target, biomarker, or disease gene, nor does it have pharmacological relevance. Essential context and supporting details: - Pseudogene status: ENSG00000271527/LOC100420658 is annotated as a pseudogene in Ensembl and other major databases[1]. It does not encode a functional protein, unlike the active gene PGAP2 (ENSG00000148985). - Nomenclature confusion: The functional gene PGAP2 (post-GPI attachment to proteins 2) is a well-characterized enzyme involved in the maturation of GPI-anchored proteins, with numerous clinical and biological implications[5][4][3]. The pseudogene does not share these functions or disease associations. - Not a drug target: As it is inactive/noncoding, it is not a therapeutic target, does not interact with drugs, and lacks known biomarkers or safety considerations. - Potential for incorrect mapping: If the intent was to retrieve information about the functional gene (PGAP2), not its pseudogene, refer instead to "Post-GPI attachment to proteins 2" (PGAP2, ENSG00000148985)[1][4][5]. Key point: The target post-GPI attachment to proteins 2 pseudogene (ENSG00000271527, LOC100420658) is not a valid therapeutic target, has no recognized biological or disease function, and is functionally and clinically distinct from the related protein-coding gene PGAP2[1].

Other names

LOC100420658